"Bezafibrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.
| Descriptor ID |
D001629
|
| MeSH Number(s) |
D02.065.277.067 D02.241.081.114.968.500.249 D02.241.223.100.100.120 D02.241.223.100.200.249 D02.355.726.305.249 D02.455.426.559.389.127.085.101 D02.455.426.559.389.127.250.249 D02.455.426.559.389.657.654.305.249
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bezafibrate".
Below are MeSH descriptors whose meaning is more specific than "Bezafibrate".
This graph shows the total number of publications written about "Bezafibrate" by people in this website by year, and whether "Bezafibrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bezafibrate" by people in Profiles.
-
A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al. Cardiovasc Drugs Ther. 2009 Oct; 23(5):341-2.
-
Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Liver Transpl. 2006 Jun; 12(6):1012-3.
-
Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab. 2004 May; 286(5):E718-24.
-
Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. Metabolism. 2001 Apr; 50(4):477-80.
-
Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients. Diabetes Care. 2000 Feb; 23(2):259.